5,337
Views
29
CrossRef citations to date
0
Altmetric
Editorial

Vaccines ‘on demand’: science fiction or a future reality

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Andrew J. Geall, Zoltan Kis & Jeffrey B. Ulmer. (2023) Vaccines on demand, part II: future reality. Expert Opinion on Drug Discovery 18:2, pages 119-127.
Read now
Oriana Simonetti, Giulia Radi, Elisa Molinelli, Giulio Rizzetto, Federico Diotallevi & Annamaria Offidani. (2021) Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management. Human Vaccines & Immunotherapeutics 17:10, pages 3268-3275.
Read now
Raj Kumar Singh, Kuldeep Dhama, Yashpal Singh Malik, Muthannan Andavar Ramakrishnan, Kumaragurubaran Karthik, Ruchi Tiwari, Sharad Saurabh, Swati Sachan & Sunil Kumar Joshi. (2016) Zika virus – emergence, evolution, pathology, diagnosis, and control: current global scenario and future perspectives – a comprehensive review. Veterinary Quarterly 36:3, pages 150-175.
Read now
Małgorzata Anna Marć, Enrique Domínguez-Álvarez & Carlos Gamazo. (2015) Nucleic acid vaccination strategies against infectious diseases. Expert Opinion on Drug Delivery 12:12, pages 1851-1865.
Read now

Articles from other publishers (25)

Maria E. Tsoumani, Chrysa Voyiatzaki & Antonia Efstathiou. (2023) Malaria Vaccines: From the Past towards the mRNA Vaccine Era. Vaccines 11:9, pages 1452.
Crossref
Cordin ArpagausCordin Arpagaus. 2023. Spray Drying of Vaccines. Spray Drying of Vaccines 325 530 .
Michael S. Firstenberg, Benjamin A. Wilson, Dianne E. McCallister & Stanislaw P. Stawicki. 2023. Blockchain in Healthcare. Blockchain in Healthcare 69 96 .
Vivek Chavda, Md Hossain, Jayesh Beladiya & Vasso Apostolopoulos. (2021) Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena. Biologics 1:3, pages 337-356.
Crossref
Richard I. Kitney, Jennifer Bell & Jim Philp. (2021) Build a Sustainable Vaccines Industry with Synthetic Biology. Trends in Biotechnology 39:9, pages 866-874.
Crossref
Jeffrey B. Ulmer & Margaret A. Liu. (2021) Path to Success and Future Impact of Nucleic Acid Vaccines: DNA and mRNA. Molecular Frontiers Journal 05:01n02, pages 38-57.
Crossref
Anna K. Blakney, Shell Ip & Andrew J. Geall. (2021) An Update on Self-Amplifying mRNA Vaccine Development. Vaccines 9:2, pages 97.
Crossref
Elie Dolgin. (2021) How COVID unlocked the power of RNA vaccines. Nature 589:7841, pages 189-191.
Crossref
Giulietta Maruggi, Jeffrey B. Ulmer, Rino Rappuoli & Dong Yu. 2022. mRNA Vaccines. mRNA Vaccines 31 70 .
Alan Stokes, Johanne Pion, Ornella Binazon, Benoit Laffont, Maude Bigras, Guillaume Dubois, Karine Blouin, Jamie K. Young, Michael A. Ringenberg, Nawel Ben Abdeljelil, Julius Haruna & Luis-Alexander Rodriguez. (2020) Nonclinical safety assessment of repeated administration and biodistribution of a novel rabies self-amplifying mRNA vaccine in rats. Regulatory Toxicology and Pharmacology 113, pages 104648.
Crossref
María Fernández-Prada, José Antonio López Trigo, José M. Bayas & María del Rosario Cambronero. (2020) Quo vadis en vacunas: desde la aproximación empírica a la nueva oleada tecnológica. Revista Española de Geriatría y Gerontología 55:3, pages 160-168.
Crossref
Anja Holm & Jeroen Kortekaas. (2020) Obstacles to vaccination of animals and prospective solutions. Biologicals 65, pages 46-49.
Crossref
Nathaniel S Wang & Christian J Maine. (2020) Integrating context of tumor biology and vaccine design to shape multidimensional immunotherapies. Future Drug Discovery 2:1.
Crossref
Mariane Melo, Ely Porter, Yuan Zhang, Murillo Silva, Na Li, Brian Dobosh, Alessia Liguori, Pat Skog, Elise Landais, Sergey Menis, Devin Sok, David Nemazee, William R. Schief, Ron Weiss & Darrell J. Irvine. (2019) Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles. Molecular Therapy 27:12, pages 2080-2090.
Crossref
Cristina Manara, Michela Brazzoli, Diego Piccioli, Marianna Taccone, Ugo D'Oro, Domenico Maione & Elisabetta Frigimelica. (2019) Co-administration of GM-CSF expressing RNA is a powerful tool to enhance potency of SAM-based vaccines. Vaccine 37:30, pages 4204-4213.
Crossref
Giulietta Maruggi, Cuiling Zhang, Junwei Li, Jeffrey B. Ulmer & Dong Yu. (2019) mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases. Molecular Therapy 27:4, pages 757-772.
Crossref
Marc P. Girard & Wayne C. Koff. 2018. Plotkin's Vaccines. Plotkin's Vaccines 400 429.e25 .
Giulietta Maruggi, Emiliano Chiarot, Cinzia Giovani, Scilla Buccato, Stefano Bonacci, Elisabetta Frigimelica, Immaculada Margarit, Andrew Geall, Giuliano Bensi & Domenico Maione. (2017) Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens. Vaccine 35:2, pages 361-368.
Crossref
Thomas Hinz, Kajo Kallen, Cedrik M. Britten, Bruno Flamion, Ulrich Granzer, Axel Hoos, Christoph Huber, Samir Khleif, Sebastian Kreiter, Hans-Georg Rammensee, Ugur Sahin, Harpreet Singh-Jasuja, Özlem Türeci & Ulrich Kalinke. 2017. RNA Vaccines. RNA Vaccines 203 222 .
Thomas Kramps & Knut Elbers. 2017. RNA Vaccines. RNA Vaccines 1 11 .
Jeffrey B Ulmer & Andrew J Geall. (2016) Recent innovations in mRNA vaccines. Current Opinion in Immunology 41, pages 18-22.
Crossref
Kenneth S. Rosenthal, Aaron Kuntz & Joseph Sikon. (2016) Why Don't We Have a Vaccine Against……….? Part 2. Bacteria. Infectious Diseases in Clinical Practice 24:2, pages 119-123.
Crossref
Sandra Lazzaro, Cinzia Giovani, Simona Mangiavacchi, Diletta Magini, Domenico Maione, Barbara Baudner, Andrew J. Geall, Ennio De Gregorio, Ugo D'Oro & Cecilia Buonsanti. (2015) CD8 T-cell priming upon mRNA vaccination is restricted to bone-marrow-derived antigen-presenting cells and may involve antigen transfer from myocytes. Immunology 146:2, pages 312-326.
Crossref
Fernando González-Romo & Juan J. Picazo. (2015) El desarrollo de nuevas vacunas. Enfermedades Infecciosas y Microbiología Clínica 33:8, pages 557-568.
Crossref
Lidewij Wiersma, Guus Rimmelzwaan & Rory de Vries. (2015) Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head. Vaccines 3:2, pages 239-262.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.